Highlights the management of malignant pericardial effusion secondary to prostate adenocarcinoma, noting the potential for recurrence after pericardiocentesis requiring a pericardial window.
Recurrence after pericardiocentesis may necessitate pericardial window in malignant effusion; leaves open optimal strategy for prostate adenocarcinoma cases.
The authors discuss a rare case of pericardial effusion secondary to carcinoma of the prostate. A month after therapeutic pericardiocentesis there was a haemodynamically significant recurrence, necessitating a pericardial window. The authors discuss pericardial effusion and the management of such patients.
No takes yet. Share an insight, caveat, or question.
Conway et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: